Compare Davita Inc (DVA) vs iShares 0 3 Month Treasury Bond ETF (SGOV) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Davita Inc vs iShares 0 3 Month Treasury Bond ETF — how do they compare? Davita Inc trades at $178.34 (market cap $11.72B), while iShares 0 3 Month Treasury Bond ETF trades at $100.51. Which is the better fit depends on your goals.
| DVA | SGOV | |
|---|---|---|
Market Cap | $11.72B | — |
Sector | Health | Fixed Income |
52-Week High | $240.96 | $100.74 |
52-Week Low | $103.87 | $100.28 |
Enterprise Value | $24.44B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DaVita (DVA) trades at $183.77, up 1.72% today, with a mixed technical picture showing bearish moving averages but bullish oscillators. The company reported strong Q2 2026 earnings of $4.02 per share, beating estimates, driven by volume growth. Revenue reached $13.64 billion in 2025, with a net income margin of 6.05%. Analyst consensus is a Buy with a $232.25 price target, though technical signals are bearish overall.
The outlook for DVA is cautiously optimistic, supported by earnings beats and volume growth, but risks include reimbursement pressure and high debt levels. The stock offers potential upside to the consensus target, yet investors face headwinds from margin compression and technical bearishness.
SGOV, the iShares 0-3 Month Treasury Bond ETF, trades at $100.48, showing minimal daily movement. The technical outlook is bearish based on moving averages, while oscillators are neutral. Recent news highlights institutional stake adjustments and investor interest in ultra-short Treasury ETFs as a defensive pivot amid market volatility, with articles noting its role as a conservative cash alternative offering a yield around 3.8% (Seeking Alpha, 2026-08-03).
The ETF provides exposure to short-term U.S. Treasury bills, benefiting from rising interest rates but facing risks from Federal Reserve policy uncertainty and inflation data. Its principal protection and monthly distributions appeal to risk-averse investors, though price appreciation is limited by its nature. Key risks include interest rate changes and macroeconomic shifts influencing Treasury yields.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Davita Inc
DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,100 facilities worldwide, mostly in the U.S., and treats over 240,000 patients globally each year. Government payers dominate U.S. dialysis reimbursement. DaVita receives approximately 69% of U.S. sales at government (primarily Medicare) reimbursement rates, with the remaining 31% coming from commercial insurers. However, while commercial insurers represented only about 10% of the U.S. patients treated, they represent nearly all of the profits generated by DaVita in the U.S. dialysis business.
Read more on DVA →About iShares 0 3 Month Treasury Bond ETF
SGOV provides exposure to ultra-short-term U.S. Treasury bills with maturities of three months or less. It functions as a high-liquidity cash alternative, seeking to provide current income while maintaining a stable net asset value and minimal interest rate risk.
Read more on SGOV →
